$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 11/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 11/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | A | 83.43 | 34,270 | 2,859,146 | 34,270 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 15,290 | 0 | 91,480 | 76.2 K to 91.5 K (+20.07 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 83.43 | 136,050 | 11,350,652 | 136,050 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 60,710 | 0 | 392,221 | 331.5 K to 392.2 K (+18.31 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | A | 83.43 | 37,290 | 3,111,105 | 37,290 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 16,640 | 0 | 63,933 | 47.3 K to 63.9 K (+35.18 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | A | 83.43 | 36,280 | 3,026,840 | 36,280 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 16,190 | 0 | 138,626 | 122.4 K to 138.6 K (+13.22 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 83.43 | 44,340 | 3,699,286 | 44,340 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 19,790 | 0 | 120,666 | 100.9 K to 120.7 K (+19.62 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 83.43 | 7,000 | 584,010 | 7,000 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 80.34 | 376 | 30,208 | 15,247 | 15.6 K to 15.2 K (-2.41 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 3,570 | 0 | 15,623 | 12.1 K to 15.6 K (+29.62 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | A | 83.43 | 36,280 | 3,026,840 | 36,280 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 16,190 | 0 | 63,072 | 46.9 K to 63.1 K (+34.53 %) |
| Mar 16 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 86.21 | 1,996 | 172,079 | 76,190 | 78.2 K to 76.2 K (-2.55 %) |